COPD Essay

Treatment for COPD Inhaled Therapies NICE COPD guidelines have made specific recommendations regarding the use of inhaled long-acting bronchodilators and inhaled steroids separately and in combination, but newer studies have assessed these drugs singly and in combination over longer periods of time. Bronchodilators (relievers) Short-acting beta2 agonists (SABA) Beta2 agonists act directly on bronchial smooth muscle to cause bronchodilation. They are the most widely used bronchodilators for COPD. Short-acting

pulmonary disease (COPD) is a condition that refers to chronic airflow limitations and is a term associated with chronic bronchitis and emphysema (American Nurse Today, 2012). According to American Nurse Today, COPD is one of the leading causes of death and disability worldwide (ANA, 2012). As nurses, it is essential to provide appropriate education to patients with COPD on home oxygen to ensure quality of life and safety. An important nursing intervention for a patient with COPD is to improve functional

Having COPD affects a person's quality of life; it's difficult not to become anxious when you cannot catch your breath. Unfortunately, it's a vicious cycle; the more anxious you become, the harder it is to breathe. Possible treatments include inhalers and other medications, oxygen therapy and lifestyle changes, however, if these options are not effective enough to improve an individual's quality of life, stem cell therapy is a way to possibly reduce the symptoms of COPD and other chronic lung diseases

doctor would listen to the patient chest with his or her stethoscope to hear how the air passes in and out of the lungs. If the doctor hear a rattle sound coming from the smaller airways, he would assume that the patient is suffering from some kind of COPD. He would observe how the patient is sitting in a chair, look for bluish lips and fingernail beds, which would mean that the patient suffer from cyanosis. Cyanosis happen when a person does not have enough oxygen in his or her blood. Also the doctor

likely bacterial causes of infective exacerbation of COPD are: Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumonia, Haemophilus parainfluenzae, Staphylococcus aureus, Pseudomonas aeruginosa, gram-negative Enterobacteriaceae, Klebsiella pneumonia and Mycoplasma pneumoniae (S.Sethi, 2004; T. Kawamatawong et al, 2017; King et al, 2013). b) Bronchodilators Bronchodilators can increase FEV1 (GOLD,2017). During an exacerbation of COPD, long acting preparations should be switched to short

Because COPD has always been thought of as a man’s disease, women are often misdiagnosed. The majority of people with COPD are smokers or former smokers. The more and longer a person smokes, the higher the risk of developing COPD. Smoking is the primary cause of COPD but pollutants in the air such as secondhand smoke or dust and fumes can cause COPD. There is also a genetic predisposition that can lead to developing COPD. The prevention plan needs to revolving around these patients in order

Pulmonary Disease (COPD) Definition: COPD is a progressive disease that makes it hard to breathe. "Progressive" means the disease get worse over time. It can cause coughing that produces large amount of mucus, wheezing, shortness of breath, chest tightness, and other symptoms. Etiology: Most cases of COPD occur as a result of long-term exposure to lung irritants that damage the lungs and the airways. In the United States, the most common irritant that causes COPD is cigarette smoke

factors for COPD. Pulmonary function test show a ratio indicating less than 70% post-bronchodilator. Post-bronchodilator improvement would suggest asthma. In this case, her COPD is moderate in nature because the ratio is between 50-79%. Persistent cough is an indicator for COPD, as well as the dyspnea and wheezing in lungs with auscultation that did not clear with bronchodilation (Khachi, Barnes, & Antoniou, 2010). There is no indication for CHF. This patient has COPD. Testing for COPD is needed

disease (COPD) remains a major financial burden to our healthcare system. In 2015, the Centers for Medicare & Medicaid Services started imposing a financial penalty for hospitals with excess rates of COPD readmissions. We investigated the effectiveness of a Discharge Checklist in reducing the rates of 30-day readmission in a cohort of high risk patients admitted with COPD exacerbation. METHODS We conducted a 12 month randomized prospective case-control study on patients diagnosed with acute COPD exacerbation

6MWT is commonly used to assess the COPD patient’s functional status. 6MWT is widely used for cardiopulmonary patients in hospital settings since it is safer, easier and cost efficient to administer than other walk tests. It better reflects activities of daily life than other walk tests and it adequately anticipates morbidity and mortality of COPD patients (Pinto-Plata et al. 2004; Enright 2003). According to Andersson et al.(2011), 6MWT has a strong reliability with an Intraclss Correlation Coefficient